Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Clinical Trials

Older people and cancer: how research could personalise treatment plans and care

We look at how research could help to adapt and improve treatment for older patients, including inclusive clinical trials and pre-habilitation.

Drug could protect children from hearing loss after chemo

New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin. We talk to the lead researcher, Dr Penelope Brock.

New drug halves hearing loss in children following cancer treatment

Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to new research.

Cancer Research UK tests first of its kind vaccine to treat lung cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

Chemoradiotherapy before surgery may extend lives of pancreatic cancer patients

Pancreatic cancer patients treated with chemotherapy and radiotherapy before surgery may live longer than those who have immediate surgery.

Combining heartburn drugs and aspirin could help prevent oesophageal cancer in people at high risk

Two over-the-counter, widely available drugs could help cut cases of oesophageal cancer in people at higher risk of the disease.

Some people with advanced kidney cancer could avoid surgery

The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer.

Breast cancer gene test could spare some women chemo

A test that measures gene activity can help tailor treatment for some women with early stage breast cancer, sparing them chemotherapy.

Trial to test new treatment combination for children and adults with leukaemia

A clinical trial testing a new treatment combination in patients with leukaemia launches through the Combinations Alliance today.

Six months of breast cancer treatment ‘could be as effective as 12’ in some women with early stage disease

Six months of treatment could be as effective as 12 months for women with a type of early stage breast cancer, according to unpublished clinical trial results.

Pages